175 related articles for article (PubMed ID: 36175662)
1. Long-term risks of malignancy in myositis-specific antibody-positive idiopathic inflammatory myopathy.
Izuka S; Komai T; Shoda H; Fujio K
Rheumatol Int; 2023 Feb; 43(2):335-343. PubMed ID: 36175662
[TBL] [Abstract][Full Text] [Related]
2. Immune cell profiles of idiopathic inflammatory myopathy patients expressed anti-aminoacyl tRNA synthetase or anti-melanoma differentiation-associated gene 5 autoantibodies.
Lan JL; Chang SH; Tsay GJ; Chen DY; Chao YH; Li JP
BMC Immunol; 2023 Sep; 24(1):33. PubMed ID: 37752437
[TBL] [Abstract][Full Text] [Related]
3. Age distribution and prevalence in different age groups of four myositis-specific autoantibodies, including anti-ARS, anti-MDA5, anti-Mi-2, and anti-TIF1γ antibodies.
Ueda-Hayakawa I; Tonomura K; Maekawa A; Kaneda E; Arase N; Fujimoto M
J Dermatol; 2023 Aug; 50(8):1058-1062. PubMed ID: 36890683
[TBL] [Abstract][Full Text] [Related]
4. Myositis-specific autoantibodies and their clinical associations in idiopathic inflammatory myopathies: results from a cohort from China.
Wen L; Chen X; Cheng Q; Nie L; Xu J; Yan T; Zhang X; Yang H; Sun W; Liu L; Xue J; Du Y
Clin Rheumatol; 2022 Nov; 41(11):3419-3427. PubMed ID: 35859245
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of myositis-specific autoantibodies.
Nakashima R
Immunol Med; 2018 Sep; 41(3):103-112. PubMed ID: 30938275
[TBL] [Abstract][Full Text] [Related]
6. Myositis-specific and myositis-associated autoantibodies in a large Indian cohort of inflammatory myositis.
Gupta L; Naveen R; Gaur P; Agarwal V; Aggarwal R
Semin Arthritis Rheum; 2021 Feb; 51(1):113-120. PubMed ID: 33360322
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive assessment of myositis-specific autoantibodies in polymyositis/dermatomyositis-associated interstitial lung disease.
Hozumi H; Fujisawa T; Nakashima R; Johkoh T; Sumikawa H; Murakami A; Enomoto N; Inui N; Nakamura Y; Hosono Y; Imura Y; Mimori T; Suda T
Respir Med; 2016 Dec; 121():91-99. PubMed ID: 27888997
[TBL] [Abstract][Full Text] [Related]
8. The Role of Myositis-Specific Autoantibodies and the Management of Interstitial Lung Disease in Idiopathic Inflammatory Myopathies: A Systematic Review.
Teel A; Lu J; Park J; Singh N; Basharat P
Semin Arthritis Rheum; 2022 Dec; 57():152088. PubMed ID: 36116345
[TBL] [Abstract][Full Text] [Related]
9. Frequencies and clinical associations of myositis-related antibodies in The Netherlands: A one-year survey of all Dutch patients.
Platteel ACM; Wevers BA; Lim J; Bakker JA; Bontkes HJ; Curvers J; Damoiseaux J; Heron M; de Kort G; Limper M; van Lochem EG; Mulder AHL; Saris CGJ; van der Valk H; van der Kooi AJ; van Leeuwen EMM; Veltkamp M; Schreurs MWJ; Meek B; Hamann D
J Transl Autoimmun; 2019 Dec; 2():100013. PubMed ID: 32743501
[TBL] [Abstract][Full Text] [Related]
10. Longitudinal changes in nailfold videocapillaroscopy findings differ by myositis-specific autoantibody in idiopathic inflammatory myopathy.
Mugii N; Hamaguchi Y; Horii M; Fushida N; Ikeda T; Oishi K; Yahata T; Someya F; Matsushita T
Rheumatology (Oxford); 2023 Mar; 62(3):1326-1334. PubMed ID: 35866689
[TBL] [Abstract][Full Text] [Related]
11. Frequency, mutual exclusivity and clinical associations of myositis autoantibodies in a combined European cohort of idiopathic inflammatory myopathy patients.
Betteridge Z; Tansley S; Shaddick G; Chinoy H; Cooper RG; New RP; Lilleker JB; Vencovsky J; Chazarain L; Danko K; Nagy-Vincze M; Bodoki L; Dastmalchi M; Ekholm L; Lundberg IE; McHugh N;
J Autoimmun; 2019 Jul; 101():48-55. PubMed ID: 30992170
[TBL] [Abstract][Full Text] [Related]
12. Cancer associated autoantibodies in idiopathic inflammatory myopathies: A retrospective cohort from a single center in China.
Zhao Y; Su H; Yin X; Hou H; Wang Y; Xu Y; Li X; Zhang N; Sun W; Wei W
Med Clin (Barc); 2023 Jan; 160(1):10-16. PubMed ID: 35842306
[TBL] [Abstract][Full Text] [Related]
13. Identification of multiple cancer-associated myositis-specific autoantibodies in idiopathic inflammatory myopathies: a large longitudinal cohort study.
Yang H; Peng Q; Yin L; Li S; Shi J; Zhang Y; Lu X; Shu X; Zhang S; Wang G
Arthritis Res Ther; 2017 Nov; 19(1):259. PubMed ID: 29178913
[TBL] [Abstract][Full Text] [Related]
14. A Comprehensive Overview on Myositis-Specific Antibodies: New and Old Biomarkers in Idiopathic Inflammatory Myopathy.
Satoh M; Tanaka S; Ceribelli A; Calise SJ; Chan EK
Clin Rev Allergy Immunol; 2017 Feb; 52(1):1-19. PubMed ID: 26424665
[TBL] [Abstract][Full Text] [Related]
15. The clinical features and prognoses of anti-MDA5 and anti-aminoacyl-tRNA synthetase antibody double-positive dermatomyositis patients.
Chen X; Zhang L; Jin Q; Lu X; Lei J; Peng Q; Wang G; Ge Y
Front Immunol; 2022; 13():987841. PubMed ID: 36110863
[TBL] [Abstract][Full Text] [Related]
16. The prognostic role of C-reactive protein to albumin ratio and anti-MDA5 antibody-positive in idiopathic inflammatory myopathy: a retrospective study.
Zhou P; Shen Q; Zhou S; Ouyang X; Guo T; Song M; Guo W; Zhang Y; Peng H
Sci Rep; 2023 Mar; 13(1):3863. PubMed ID: 36890164
[TBL] [Abstract][Full Text] [Related]
17. Prognosis of adult idiopathic inflammatory myopathy-associated interstitial lung disease: a retrospective study of 679 adult cases.
Li S; Sun Y; Shao C; Huang H; Wang Q; Xu K; Zhang X; Liu P; Zeng X; Xu Z
Rheumatology (Oxford); 2021 Mar; 60(3):1195-1204. PubMed ID: 32894294
[TBL] [Abstract][Full Text] [Related]
18. Long-Term Outcomes and Prognosis Factors in Patients With Idiopathic Inflammatory Myopathies Based on Myositis-Specific Autoantibodies: A Single Cohort Study.
Jiang W; Shi J; Yang H; Tian X; Yang H; Chen Q; Zhang L; Peng Q; Wang G; Lu X
Arthritis Care Res (Hoboken); 2023 May; 75(5):1175-1182. PubMed ID: 35921214
[TBL] [Abstract][Full Text] [Related]
19. Interstitial Lung Disease in Dermatomyositis Without Myositis-Specific and Myositis-Associated Autoantibodies: Study of a Series of 72 Patients From a Single Cohort.
Chen F; Wang J; Zhang P; Zuo Y; Ye L; Wang G; Shu X
Front Immunol; 2022; 13():879266. PubMed ID: 35603153
[TBL] [Abstract][Full Text] [Related]
20. Autoantigenic properties of the aminoacyl tRNA synthetase family in idiopathic inflammatory myopathies.
Preger C; Notarnicola A; Hellström C; Wigren E; Fernandes-Cerqueira C; Kvarnström M; Wahren-Herlenius M; Idborg H; Lundberg IE; Persson H; Gräslund S; Jakobsson PJ
J Autoimmun; 2023 Jan; 134():102951. PubMed ID: 36470210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
